Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.
about
Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@en
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@nl
type
label
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@en
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@nl
prefLabel
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@en
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@nl
P2093
P2860
P50
P1433
P1476
Intravenous Ferric Carboxymalt ...... ial Study Design and Protocol.
@en
P2093
Andreas L Birkenfeld
Carsta Köhler
Christoph Hasslacher
Christoph Schindler
Diethelm Tschöpe
Martin Grüneberg
Ulrike Schatz
P2860
P2888
P356
10.1007/S13300-017-0330-Z
P577
2017-11-13T00:00:00Z
P6179
1092657170